Page last updated: 2024-10-15

helospectin i

Description

helospectin I: 38 residue peptide from Gila monster (Heloderma suspectum) venom; amino acid sequence given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16132375
MeSH IDM0126858

Synonyms (5)

Synonym
exendin-1
helospectin i
93438-37-0
exendin 1
DTXSID20239431

Research Excerpts

Overview

Helospectin I is a 38-residue peptide, His-Ser-Asp-Ala-Thr-Phe- thr-AlA-Glu-Tyr-Ser. HelospectIn II is a 37-resilient peptide identical to helospectins I and II except that it lacks serine 38.

ExcerptReference
"Helospectin I is a 38-residue peptide, His-Ser-Asp-Ala-Thr-Phe-Thr-Ala-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala- Leu-Gln - Lys-Tyr-Leu-Glu-Ser-Ile-Leu-Gly-Ser-Ser-Thr-Ser-Pro-Arg-Pro-Pro-Ser-Ser, and helospectin II is a 37-residue peptide identical to helospectin I except that it lacks serine 38."( Amino acid sequences of helospectins, new members of the glucagon superfamily, found in Gila monster venom.
Bledsoe, M; O'Donohue, TL; Parker, DS; Pisano, JJ; Raufman, JP; Yoshida, H, 1984
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's14 (53.85)18.2507
2000's3 (11.54)29.6817
2010's5 (19.23)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.41%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (3.70%)0.25%
Other24 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]